<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beigel</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Tomashek</surname>
    <given-names>K. M.</given-names>
   </name>
   <name>
    <surname>Dodd</surname>
    <given-names>L. E.</given-names>
   </name>
   <name>
    <surname>Mehta</surname>
    <given-names>A. K.</given-names>
   </name>
   <name>
    <surname>Zingman</surname>
    <given-names>B. S.</given-names>
   </name>
   <name>
    <surname>Kalil</surname>
    <given-names>A. C.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>Remdesivir for the Treatment of Covid-19 — Preliminary Report</article-title>. 
  <source>N. Engl. J. Med.</source>
  <volume>4</volume> (
  <issue>2</issue>), 
  <fpage>93</fpage>–
  <lpage>107</lpage>. 
  <pub-id pub-id-type="doi">10.4049/immunohorizons.2000002</pub-id>
 </mixed-citation>
</ref>
